12 Health Care Stocks Moving In Friday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Friday's after-market session, several healthcare stocks showed notable movements. Bluejay Diagnostics, China Pharma Holdings, and Imunon were among the top gainers, with increases of 11.0%, 10.15%, and 7.63% respectively. On the losing end, Compass Therapeutics, Akanda, and Portage Biotech saw significant declines. Accolade also rose by 5.83% following their Q4 earnings release.
April 26, 2024 | 8:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Accolade's shares rose by 5.83% to $8.35 following their Q4 earnings release, with a market cap of $646.3 million.
The positive movement in Accolade's stock price post-earnings suggests the market reacted favorably to their Q4 results.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 95
POSITIVE IMPACT
Bluejay Diagnostics saw an 11.0% increase to $0.73, with a market cap of $1.9 million.
The significant after-market gain suggests positive investor sentiment, potentially due to unmentioned catalysts or broader market trends.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
China Pharma Holdings' stock rose by 10.15% to $0.33.
The rise in stock price could indicate positive market reaction to industry or company-specific news not detailed in the article.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 90
POSITIVE IMPACT
Imunon's shares increased by 7.63% to $1.55, with a market cap of $14.5 million.
The increase in Imunon's stock price may reflect investor optimism or reactions to recent company developments.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
Akanda's shares fell by 7.77% to $0.1, with a market cap of $1.1 million.
Akanda's stock price drop suggests a negative reaction from investors, possibly due to adverse events or market conditions.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 90
NEGATIVE IMPACT
Compass Therapeutics stock decreased by 8.3% to $1.33, with a market cap of $182.9 million.
The decline in Compass Therapeutics' stock price could be due to negative market sentiment or disappointing company news.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90